NFKBIZ and hepatocellular carcinoma: Combined with our previous observation that 84.9% of NFKBIZ+ macrophages are enriched in the non-pCR group, these data collectively suggest that the angiogenesis gene set expressed by NFKBIZ+ macrophages may play a key role in mediating ICB resistance in HCC.